Dateline City:
WHITEHOUSE STATION, N.J.
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada,
will hold its second-quarter 2013 sales and earnings conference call
with institutional investors and analysts at 8:00 a.m. EDT on Tuesday,
July 30. During the call, Kenneth C. Frazier, chairman and chief
executive officer; Peter N. Kellogg, executive vice president and chief
financial officer; and Adam H. Schechter, president, Global Human
Health, will provide an overview of Mercks financial performance for
the quarter.
Language:
English
Contact:
MerckMedia:Steven Cragle, 908-423-3461orKelley Dougherty, 908-423-4291orInvestors:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088
Ticker Slug:
Ticker: MRK Exchange: NYSE
read more